|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200209019
Lampugnani et al.
• Figure S1 Accessibility of VEGFR-2 in VEC-null and -positive cells.
• Figure S2 Confluent VEC-null and -positive endothelial cells were stimulated with VEGF (80 ng/ml) for 10 and 160 min.
• Figure S3 Inhibition of phosphotyrosine phosphatases with pervanadate releases the inhibition of VEGFR-2 tyrosine phosphorylation in VEC-positive endothelial cells.
• Figure S4 Immunofluorescence microscopy of VEC-positive cells transfected with DEP-1 wt, DEP-1 C/S, DEP-1 siRNA, and scramble (scr) siRNA.
• Figure S5 DEP-1 C/S point mutated in the cysteine residue 1239 essential for tyrosine phosphatase activity increases VEGFR-2 phosphorylation at tyr 996 and 951.
• Figure S6 Tyrosine phosphorylation of VEGFR-2 in sparse and confluent VEC-positive cells transfected with DEP-1 wt or DEP-1 C/S.
| ||||||||||||||||||||||||||
|
|
